Windtree Therapeutics, Inc. (NasdaqCM: WINT) recently showcased promising data on istaroxime, an investigational treatment ...

According to Business Research Insights the Cardiogenic Shock Treatment Market expected to exhibit a CAGR of 7% by 2032. The “Cardiogenic Shock Treatment Market” Research is your essential resource ...

A cardiovascular specialty hospital in north Texas decreased time to diagnosis for patients with cardiogenic shock by more ...

My name is Vakkaleri Nischitha Kumari and I am raising funds for my daughter, B.S Shanvika who is suffering from Refractory cardiogenic shock (RCS) and is undergoing treatment at Star Hospitals, ...

Sex does not affect the prognosis once cardiogenic shock is established in patients with cardiogenic shock due to Takotsubo syndrome. Management and treatment of cardiogenic shock due to Takotsubo ...

"Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut ...

Physicians have a new treatment option for many of the sickest pediatric patients with heart failure and cardiogenic shock. Johnson & Johnson MedTech, the global leader in heart recovery, announced ...

Cardiogenic shock (CS) is a life-threatening condition leading to poor prognosis and high ... On one hand, the relative shortage of anti-arrhythmic drugs without significant side effects in terms of ...

Danvers: Johnson & Johnson MedTech, has announced that the U.S. Food and Drug Administration (FDA) has expanded the ...

40 hours with a standard deviation of .37 hours. "Early recognition of patients with cardiogenic shock allows for prompt treatment initiation," the study authors wrote. "Timely intervention can ...